Nutriband (NASDAQ:NTRB) Trading Down 2.3% – Time to Sell?

Nutriband Inc. (NASDAQ:NTRB) shares traded down 2.3% during mid-day trading on Tuesday . The stock traded as low as $3.72 and last traded at $3.75. 9,024 shares changed hands during mid-day trading, a decline of 39% from the average session volume of 14,789 shares. The stock had previously closed at $3.84.

Nutriband Trading Down 2.3%

The company has a debt-to-equity ratio of 0.01, a quick ratio of 7.35 and a current ratio of 7.52. The stock has a market capitalization of $45.68 million, a price-to-earnings ratio of -1.22 and a beta of 1.78. The business has a fifty day simple moving average of $4.28 and a 200 day simple moving average of $5.35.

Hedge Funds Weigh In On Nutriband

An institutional investor recently bought a new position in Nutriband stock. Cogent Private Wealth Inc. purchased a new position in shares of Nutriband Inc. (NASDAQ:NTRB) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 16,014 shares of the company’s stock, valued at approximately $73,000. Cogent Private Wealth Inc. owned 0.13% of Nutriband as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 19.70% of the company’s stock.

Nutriband Company Profile

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.